Geode Capital Management, LLC Gossamer Bio, Inc. Transaction History

Geode Capital Management, LLC

  • $1.07 Trillion
  • Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,283,618 shares of GOSS stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,283,618
Previous 2,272,925 0.47%
Holding current value
$2.06 Million
Previous $2.07 Million 30.27%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.8 - $1.51 $8,554 - $16,146
10,693 Added 0.47%
2,283,618 $2.69 Million
Q4 2023

Feb 13, 2024
BUY
$0.48 - $1.08 $51,526 - $115,933
107,346 Added 4.96%
2,272,925 $2.07 Million
Q3 2023

Nov 13, 2023
BUY
$0.78 - $1.82 $1.09 Million - $2.54 Million
1,396,420 Added 181.55%
2,165,579 $1.8 Million
Q2 2023

Aug 11, 2023
SELL
$0.98 - $1.53 $565,558 - $882,963
-577,100 Reduced 42.87%
769,159 $922,000
Q1 2023

May 15, 2023
BUY
$0.96 - $2.92 $49,099 - $149,343
51,145 Added 3.95%
1,346,259 $1.7 Million
Q4 2022

Feb 13, 2023
BUY
$1.74 - $12.87 $63,240 - $467,760
36,345 Added 2.89%
1,295,114 $2.81 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $1.68 Million - $3.46 Million
232,714 Added 22.68%
1,258,769 $15.1 Million
Q2 2022

Aug 12, 2022
SELL
$5.97 - $9.97 $22,518 - $37,606
-3,772 Reduced 0.37%
1,026,055 $8.59 Million
Q1 2022

May 13, 2022
BUY
$8.44 - $12.49 $141,319 - $209,132
16,744 Added 1.65%
1,029,827 $8.94 Million
Q4 2021

Feb 11, 2022
BUY
$10.12 - $14.07 $175,298 - $243,720
17,322 Added 1.74%
1,013,083 $11.5 Million
Q3 2021

Nov 12, 2021
BUY
$7.25 - $13.23 $532,635 - $971,968
73,467 Added 7.97%
995,761 $12.5 Million
Q2 2021

Aug 13, 2021
BUY
$8.0 - $9.75 $613,600 - $747,825
76,700 Added 9.07%
922,294 $7.49 Million
Q1 2021

May 12, 2021
BUY
$8.63 - $10.94 $591,992 - $750,451
68,597 Added 8.83%
845,594 $7.82 Million
Q4 2020

Feb 12, 2021
SELL
$8.3 - $13.59 $97,193 - $159,138
-11,710 Reduced 1.48%
776,997 $7.51 Million
Q3 2020

Nov 13, 2020
BUY
$11.3 - $14.75 $419,557 - $547,652
37,129 Added 4.94%
788,707 $9.79 Million
Q2 2020

Aug 13, 2020
BUY
$9.52 - $15.98 $1.52 Million - $2.56 Million
159,982 Added 27.04%
751,578 $9.77 Million
Q1 2020

May 14, 2020
BUY
$8.0 - $15.48 $513,528 - $993,676
64,191 Added 12.17%
591,596 $6 Million
Q4 2019

Feb 13, 2020
BUY
$14.82 - $26.79 $404,734 - $731,634
27,310 Added 5.46%
527,405 $8.24 Million
Q3 2019

Nov 12, 2019
BUY
$16.02 - $22.47 $4.12 Million - $5.78 Million
257,106 Added 105.81%
500,095 $8.4 Million
Q2 2019

Aug 14, 2019
BUY
$16.12 - $22.89 $564,071 - $800,966
34,992 Added 16.82%
242,989 $5.39 Million
Q1 2019

May 14, 2019
BUY
$17.58 - $23.97 $3.66 Million - $4.99 Million
207,997 New
207,997 $4.51 Million

Others Institutions Holding GOSS

# of Institutions
114
Shares Held
190M
Call Options Held
405K
Put Options Held
490K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $84.6M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email